(XERS) – New Coverage
-
Oppenheimer Starts Xeris Pharmaceuticals (XERS) at Outperform, 'successful commercial execution will continue to drive top-line growth'
-
Craig-Hallum Starts Xeris Pharmaceuticals (XERS) at Buy
-
-
-
-
-
-
-
-
-
-
-
-
Back to XERS Stock Lookup